3rdPartyFeeds

Merck Begins Testing Covid-19 Vaccine Candidate

• The Wall Street Journal reported that Merck’s Covid-19 vaccine candidate will begin a Phase 1/2 trial to evaluate safety and whether or not the vaccine creates an immune response to the novel coronavirus. • Wildfires continued to spread in Northwest Oregon, causing the estimated number of evacuations in the state to increase to about 500,000, the Associated Press reported. • China National Biotec Group, a subsidiary of state-owned (1099) said it had injected hundreds of thousands of people with two experimental vaccines, even though Phase 3 trials on the vaccines hadn’t yet been completed. Read More...

• The Wall Street Journal reported that Merck’s Covid-19 vaccine candidate will begin a Phase 1/2 trial to evaluate safety and whether or not the vaccine creates an immune response to the novel coronavirus. • Wildfires continued to spread in Northwest Oregon, causing the estimated number of evacuations in the state to increase to about 500,000, the Associated Press reported. • China National Biotec Group, a subsidiary of state-owned (1099) said it had injected hundreds of thousands of people with two experimental vaccines, even though Phase 3 trials on the vaccines hadn’t yet been completed.

Read More

Add Comment

Click here to post a comment